T 2227/14 (Polynucleotide arrays/ILLUMINA) du 31.01.2018
- Identifiant européen de la jurisprudence
- ECLI:EP:BA:2018:T222714.20180131
- Date de la décision
- 31 janvier 2018
- Numéro de l'affaire
- T 2227/14
- Requête en révision de
- -
- Numéro de la demande
- 07008271.4
- Classe de la CIB
- C12Q 1/68B01J 19/00
- Langue de la procédure
- Anglais
- Distribution
- Non distribuées (D)
- Téléchargement
- Décision en anglais
- Versions JO
- Aucun lien JO trouvé
- Autres décisions pour cet affaire
- -
- Résumés pour cette décision
- -
- Titre de la demande
- Methods of sequencing polynucleotide arrays, and preparation methods therefor
- Nom du demandeur
- Illumina Cambridge Limited
- Nom de l'opposant
- Kilger, Christian
- Chambre
- 3.3.08
- Sommaire
- -
- Dispositions juridiques pertinentes
- European Patent Convention Art 111(1)European Patent Convention Art 113(1)European Patent Convention Art 114(2)European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 76(1)European Patent Convention Art 83European Patent Convention Art 84European Patent Convention R 103(1)(a)European Patent Convention R 80Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Mots-clés
- Admission main request (yes)
Admission objections under Articles 76(1), 100(b), 123(2) EPC, Rule 80 EPC (no)
Main request - extension of protection (no); clarity (yes); novelty (yes); inventive step (yes)
Apportionment of costs and refund of appeal fee (no)
Remittal for adaptation of the description (yes) - Exergue
- -
- Affaires citantes
- T 1221/19
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent with the following claims and a description to be adapted:
Claims:
Nos. 1 to 13 of the main request received during the oral proceedings before the board on 31 January 2018.